Liraglutide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Liraglutide Injection (injection) from Meitheal Pharmaceuticals, Inc. with status Current. The shortage was first posted on 07/18/2023. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Meitheal Pharmaceuticals, Inc.
- Package NDC
- 71288-563-85
- Dosage Form
- Injection
- Presentation
- Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)
- Initial Posting
- 07/18/2023
- Revised Date
Reason
Other